Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07458958Recruiting
Fall prevention program for community seniors
This trial tests a fall prevention program for older adults living in the community. It aims to help you learn how to reduce your risk of falling and stay safe on your feet.
Guangzhou, GuangdongAges 60–80 - NCT07664904Recruiting
Periostin protein levels and quality of life in back pain patients
This study looks at how a protein called periostin relates to back function and quality of life in people with disc herniations or spinal stenosis. You'll fill out two questionnaires and have your periostin measured from a blood draw or MRI.
Daegu, DaeguAges 20–80 - NCT07047456RecruitingPhase 3
Stem cell infusion timing and graft-versus-host disease risk in blood cancer patients
This trial looks at whether the time when stem cells are infused affects the chance of developing graft-versus-host disease (aGVHD) after a cord blood transplant. It may help find the best timing to improve outcomes for people with blood cancers.
Hefei, AnhuiAges Any age - NCT06478394Recruiting
Blood test for hidden stomach cancer spread
This study tests a new blood test that uses machine learning to find hidden stomach cancer spread (peritoneal metastases) early. It could help people with locally advanced stomach cancer avoid unnecessary surgery.
Shijiazhuang, HebeiAges 18 years+ - NCT07660341RecruitingPhase 1
Study of CGB3002 in healthy volunteers
This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.
Melbourne, VictoriaAges 18–55 - NCT07480057Recruiting
Bone health changes after liver transplant
This study tracks how liver transplantation affects your bone density and mineral metabolism. It aims to find changes early, which can help prevent fractures later.
New Delhi, National Capital Territory of DelhiAges 18 years+ - NCT07498686Recruiting
Blood test for Parkinson's disease
This study is testing whether a simple blood test can help doctors better understand Parkinson's disease by looking at how a protein called alpha-synuclein behaves. It aims to find a new way to diagnose and track the disease.
Beijing, Beijing MunicipalityAges 18–95 - NCT06060769Recruiting
MRI risk assessment for liver cancer in chronic liver disease
This study uses special MRI scans to better predict liver cancer risk in people with chronic liver disease. It may help doctors identify high-risk patients earlier and improve monitoring.
Zhuhai, GuangdongAges 18 years+ - NCT06368726Enrolling by invitationPhase 1
Brain stimulation for kids with autism and genetic changes
This trial tests a gentle brain stimulation treatment called tDCS for children with autism or related conditions who also have certain genetic changes. It may help improve symptoms if your child meets the specific health and birth history requirements.
Albuquerque, New MexicoAges 6–11 - NCT05584397Enrolling by invitation
Compare immune activity and HIV hidden reservoir on two treatments
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
Seattle, WashingtonAges 18–65 - NCT06763432Recruiting
Colonoscopy readiness study
This study helps patients aged 45–75 at Codman Square Health Center get ready for a colonoscopy to screen for colon cancer. It aims to make the process easier and more comfortable.
Boston, MassachusettsAges 45–75 - NCT07501468Recruiting
Comparing two breathing devices for shoulder surgery
This trial tests two types of breathing tubes (SafeLM and I-gel) to see which works better for people having shoulder surgery while sitting up. It aims to find a safer way to keep your airway open during the procedure.
Ankara, AnkaraAges 18–80 - NCT07498244Recruiting
Collagen fingerprinting to understand lung blood pressure
This study uses a special imaging method to look at collagen (a building block of lung tissue) in people with COPD or pulmonary fibrosis. Researchers want to see if collagen patterns can help doctors better understand and treat high blood pressure in the lungs (pulmonary hypertension).
Graz, StyriaAges 18 years+ - NCT07123545RecruitingPhase 1/Phase 2
Personalized T-cell therapy for advanced liver cancer
This trial tests a personalized treatment using your own immune cells (T-cells) trained to attack specific markers on your liver cancer. It is for people with advanced liver cancer that has worsened after at least two prior treatments and who have tumor tissue available for genetic testing.
Hangzhou, ZhejiangAges 18–75 - NCT06483074RecruitingPhase 2
Empagliflozin to preserve kidney function in new peritoneal dialysis patients
This trial tests whether empagliflozin, a medication originally for diabetes, can help protect the remaining kidney function in people who have just started peritoneal dialysis. If you started dialysis within the last 3 months and still make some urine, this study may be a good fit.
Hong KongAges 18–75 - NCT04545112Enrolling by invitation
Testing a new heart bypass graft in people needing multi-vessel CABG
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
LeuvenAges 18 years+ - NCT07486037Recruiting
Exercise program for African American Alzheimer's caregivers
This study is for African American caregivers of someone with Alzheimer's or a related dementia. It explores whether a gentle exercise program can help you feel better and manage the stress of caregiving.
Indianapolis, IndianaAges 18–99 - NCT07481669RecruitingPhase 2
Stem cell transplant for lymphoma at high risk of brain relapse
This trial tests a stem cell transplant with a special chemo combination (TEAM) to see if it can prevent lymphoma from coming back in the brain or spinal cord for people with high-risk non-Hodgkin lymphoma.
Hangzhou, ZhejiangAges 18–70 - NCT07127471Recruiting
Comparing two colonoscopy methods for finding pre-cancerous polyps
This study tests two different colonoscopy techniques to see which one finds more pre-cancerous polyps called serrated lesions. It may help your doctor choose the best way to screen for colon cancer during your procedure.
Montreal, QuebecAges 40–80 - NCT07450950Recruiting
Learning from patients before and after major cancer surgery
This trial looks at how people understand health information and what they expect before and after major cancer surgery. The goal is to help doctors better support patients by learning about their hopes and possible regrets.
Copenhagen, CopenhagenAges 18 years+ - NCT07462546Recruiting
Ultrasound monitoring during carotid artery stenting
This trial is testing a special ultrasound (called transcranial Doppler) to monitor blood flow during a procedure to open a narrowed carotid artery in your neck. The ultrasound helps doctors see if the procedure is safe and working well.
ShenyangAges 40 years+ - NCT07459244Recruiting
ECG changes in people who use methamphetamine
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
Elâzığ, ElâzığAges 18–65 - NCT07459257Recruiting
Predicting psychiatric symptoms in methamphetamine psychosis
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
Elâzığ, ElâzığAges 18–65 - NCT07399769RecruitingPhase 1/Phase 2
MSLN CAR-T therapy for advanced solid tumors
This trial tests a new immune cell therapy called MSLN CAR-T for people with advanced solid tumors that have spread or cannot be removed by surgery. It may help if your cancer has not responded to standard treatment and tests positive for a protein called mesothelin (MSLN).
Shenzhen, Other (Non U.s.)Ages 18–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.